~~<i id='982E9CEAB5'><strike id='982E9CEAB5'><tt id='982E9CEAB5'><pre id='982E9CEAB5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：hotspot 2025-08-17 00:02:39 - browse：241

Photo illustration of a single pill on a large white field – opinion coverage from STAT — Adobe

This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act.

One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law.

Unfortunately, the exemptions aren’t working as intended. Unless Congress acts, the IRA threatens to unravel one of America’s greatest medical and public policy success stories: the explosion of new treatments for patients living with rare diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Fetal surgery at risk from Dobbs and new abortion restrictions

focus

entertainment

hotspot

focus

entertainment

AdobeFlagshipPioneering,theventurecapitalfirmbehindModerna,onTuesdayunveiledanewbiotechcalledQuotien

WSS

30 years of 'Listening to Prozac'

What to watch for from Zogenix and Amicus clinical trials

New lawsuit accuses health insurer Cigna of denying claims in bulk

Former reverend arrested for allegedly killing 8

30 years of 'Listening to Prozac'

Search called off for baby washed away in Pennsylvania flash flood

focus

leisure time

focus

In Memoriam: Notable people who died in 2023

Will the market for weight loss drugs really reach $100 billion?

Drug repurposing or repositioning? The language matters

New lawsuit accuses health insurer Cigna of denying claims in bulk

Walensky prepares to leave CDC — and Congress — behind

30 years of 'Listening to Prozac'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A new crop of companies is reshaping the health data economy

Medical records are filled with copy

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

focus

Organ aging and disease risk measured by new blood test

Will the market for weight loss drugs really reach $100 billion?

What to do when lifesaving products contribute to climate change

Flagship Pioneering launches a new biotech in two countries

Former reverend arrested for allegedly killing 8

The haunting brain science of long Covid

entertainment

hotspot

focus

entertainment